多発性硬化症による歩行障害のための治療用デバイス、FDAが販売を承認
Helius Medical Technologies’ groundbreaking PoNS device for short-term treatment of gait deficit due to multiple sclerosis has received marketing authorization from the U.S. Food and Drug Administration (FDA).
Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test
Cambridge Consultants developed the ground-breaking optics technology powering Ellume’s FDA authorized COVID-19 Home Test
DSP Concepts and Cambridge Consultants work to accelerate audio and voice innovation
Cambridge Consultants adds new IP to Audio Weaver, pushes audio boundaries, brings decades of integrated systems expertise
Cambridge Consultants building the world’s largest commercial airborne antenna
Cambridge Consultants working in collaboration with Stratospheric Platforms Ltd unveils a wireless antenna unlike anything seen before, delivering affordable 5G connectivity from a fleet of zero-emissions aircraft.
Flowfect™ Tx Revealed
Cambridge Consultants & Kytopen announce the initial release of the Flowfect™ Tx System, a breakthrough that will help deliver the full promise of cell therapies to tackle disease.
Flylogix and Cambridge Consultants to send drones beyond the horizon
Flylogix will exploit Iridium’s state-of-the-art satellite communications to enable unmanned aerial vehicles to perform remote monitoring of offshore installations.